PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChenavari Toro Regulatory News (TORO)

Share Price Information for Chenavari Toro (TORO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.512
Bid: 0.494
Ask: 0.53
Change: 0.00 (0.00%)
Spread: 0.036 (7.287%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.512
TORO Live PriceLast checked at -
Chenavari Toro Income is an Investment Trust

To deliver an absolute return primarily investing and trading in ABS and other structured credit investments in liquid markets, and investing in asset backed transactions including through the origination of credit portfolios.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Brexit Impact on Toro Limited

27 Jun 2016 17:00

RNS Number : 3978C
Toro Limited
27 June 2016
 

Toro Limited

27 June 2016

Brexit impact on Toro Limited

 

The Portfolio Manager would like to share their first thoughts with Toro Limited ("Toro" or the "Company") investors as to the impact of the "Brexit" vote on the European ABS market and performance of the Toro portfolio, as well as the potential consequences of Brexit on the strategy.

 

Initial impact on the European ABS market and Toro performance

Following an initial sharp sell-off in risky assets, the European credit market rebounded as Friday morning progressed (iTraxx Xover retraced 50bps from the intra-day wide levels of 450bps). The European ABS market was rather calm and orderly with decent buying inquiries across the spectrum initially and no forced sellers in sight. Indeed, bottom fishers emerged and bids across the stack improved to clear on the following levels: UK non-conforming senior RMBS at a discount margin of 210bps (+50bps), BBB CLO 2.0 tranches traded at a discount margin of 475bps (+75bps) and Spanish high beta senior RMBS at a discount margin of 475bps (+100bps) just to name a few.

Therefore, benchmarking Toro's positions to these levels and extrapolating for other sectors, we would expect the Company's exposure to Public ABS to be marked down by 3% (gross estimate subject to revisions). Public ABS represented 61.7% of the NAV as at 31 May 2016.

On the Private Asset Backed Finance strategy, exposure to CLO warehouse will also be marginally marked down although offers on leveraged loans in performing high quality credits remained at or above par as there were few forced sellers and ample cash positions within recently printed CLOs.

Toro's large cash position (22%), low leverage ratio (78%) and hedging policy reflected a defensive positioning that we have been advocating for months, ahead of this binary event. Such mitigating factors are likely to offset the mark-to-market losses and Toro's NAV is expected to be marginally down month-to-date (-1% to 0%).

 

Consequences of Brexit on the strategy

Clearly, the capacity of the Portfolio Manager to assess the impact of Brexit is limited until a post-Brexit trajectory is agreed by the UK and the EU or at least proposed by the incoming Prime Minister. There is a lot of uncertainty ahead, but also some offsetting factors such as policy responses from central banks and political bodies in the UK and abroad that would dampen expected market volatility.

Brexit is likely to harm the UK economy first as both investments and consumption wane. A mild recession could be accompanied by falling real estate prices, increasing arrears and default rates affecting directly UK consumer ABS transactions. Exposure to UK assets in Toro (especially non-conforming and buy-to-let RMBS) was reduced significantly in Q1 2016. The Portfolio Manager has stress tested the remaining 6.5% of UK RMBS exposure and expects no losses under such a scenario. Indirect exposure to UK corporate through the CLOs is 2.2% and benefits from limited exposure to domestic consumer risk.

The overall European economy is also expected to be impacted and, although the current short term outlook remains benign and technically supported by the ECB's accommodative stance, the UK referendum could trigger further political instability in the EU. Therefore, the Portfolio Manager expects to continue to manage actively tail risk hedges. Both mortgage loan origination in Europe and Leveraged loans CLO formation are also likely to slowdown, potentially delaying the implementation of the origination strategy.

The increase degree of risk aversion in the market is also likely to last, as uncertainty from a Brexit should remain in place for an extended period of time given the complexity and duration of the process. A calm and opportunistic approach to investment, made possible by Toro's capital structure, should create better entry points both on liquid and illiquid assets as markets adjust to the new reality.

 

 

Enquiries:

Kirstie McLaren

Chenavari Investment Managers

Email: tlir@chenavari.com

Telephone: +44 207 259 3600

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUBUVRNSANUAR
Date   Source Headline
20th Apr 20185:03 pmRNSNet Asset Value(s)
20th Apr 20184:00 pmRNSDividend Declaration
13th Apr 20187:00 amRNSNotification of Major Shareholding
10th Apr 20185:40 pmRNSIncrease in Concert Party
26th Mar 20184:00 pmRNSFactsheet Available - February 2018
20th Mar 20183:00 pmRNSNet Asset Value(s)
19th Mar 20183:00 pmRNSResult of AGM
13th Mar 20187:00 amRNSAppointment of Corporate Broker
28th Feb 20182:00 pmRNSFactsheet Available - January 2018
22nd Feb 201811:00 amRNSNet Asset Value(s)
16th Feb 20185:00 pmRNSScrip Dividend Election Price
16th Feb 20184:45 pmRNSNotice of AGM
31st Jan 20187:00 amRNSReplacement Dividend Declaration
25th Jan 20187:00 amRNSDividend Declaration
24th Jan 20184:30 pmRNSFactsheet Available - December 2017
24th Jan 201810:00 amRNSNet Asset Value(s)
23rd Jan 20187:00 amRNSAnnual Financial Report
28th Dec 201712:00 pmRNSFactsheet available - November 2017
20th Dec 201711:30 amRNSNet Asset Value(s)
7th Dec 20172:00 pmRNSDirector Declaration
1st Dec 20172:30 pmRNSResults of Scrip Dividend
23rd Nov 20174:30 pmRNSFactsheet Available - October 2017
20th Nov 20172:30 pmRNSNet Asset Value(s)
15th Nov 20173:00 pmRNSResult of EGM
26th Oct 20174:00 pmRNSFactsheet Available - September 2017
24th Oct 20174:09 pmRNSNotice of GM re Scrip Dividend and Name Change
23rd Oct 20173:00 pmRNSNotice of GM re Scrip Dividend and Name Change
20th Oct 20177:00 amRNSDividend Declaration
19th Oct 20174:45 pmRNSNet Asset Value(s)
9th Oct 20174:00 pmRNSPerformance Attribution Call
25th Sep 20174:30 pmRNSFactsheet Available - August 2017
20th Sep 20173:00 pmRNSNet Asset Value(s)
24th Aug 201711:45 amRNSFactsheet Available - July 2017
17th Aug 20174:30 pmRNSNet Asset Value(s)
26th Jul 20179:05 amRNSDividend Declaration - Replacement
26th Jul 20177:00 amRNSDividend Declaration
20th Jul 20174:00 pmRNSFactsheet Available - June 2017
19th Jul 20174:00 pmRNSNet Asset Value(s)
4th Jul 20174:00 pmRNSPerformance Attribution Call
27th Jun 201710:30 amRNSFactsheet Available - May 2017
26th Jun 20177:00 amRNSBarron's Top 100 Hedge Funds Ranking
21st Jun 201712:00 pmRNSNet Asset Value(s)
26th May 20177:00 amRNSHalf-year Report
24th May 20174:00 pmRNSFactsheet Available - April 2017
17th May 20173:30 pmRNSNet Asset Value(s)
12th May 20177:00 amRNSIncreased Dividend Target
2nd May 20177:00 amRNSTransaction in Own Shares
28th Apr 20177:00 amRNSTransaction in Own Shares
25th Apr 20177:00 amRNSTransaction in Own Shares
24th Apr 20174:45 pmRNSFactsheet Available - March 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.